⌘K

Login Start Free

Home/Filings/4/0001140361-08-020335

4//SEC Filing

Beever Charles 4

Accession 0001140361-08-020335

CIK 0001228627other

View on SEC.gov Company Profile

Filed

Aug 26, 8:00 PM ET

Accepted

Aug 27, 4:49 PM ET

Size

8.4 KB

Accession

0001140361-08-020335

Insider Transaction Report

Form 4

Period: 2008-06-30

REXAHN PHARMACEUTICALS, INC.RNN

Director

Transactions

Award
Stock Options (right to buy)
2008-06-30+20,000→ 20,000 total
Exercise: $3.24Exp: 2018-06-30→ Common Stock (20,000 underlying)

Holdings

Stock Options (right to buy)
Exercise: $1.20From: 2007-05-01Exp: 2016-05-01→ Common Stock (20,000 underlying)
20,000

Footnotes (1)

[F1]These options vest and become exercisable in full on June 30, 2009.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

Entity typeother

Related Parties

1

filerCIK 0001361687

Filing Metadata

Form type: 4
Filed: Aug 26, 8:00 PM ET
Accepted: Aug 27, 4:49 PM ET
Size: 8.4 KB

View on SEC.gov